 |
|
|
| |
People With HIV in the United States (US) Switching to Cabotegravir + Rilpivirine Long-Acting (CAB+RPV LA)
From Oral Antiretroviral Therapy (ART) Have Numerous Real-World Benefits, Including High Adherence and
Treatment Satisfaction
|
| |
| |
IDWeek 2024 Oct 16-19 LA, Calif.
Andrew P. Brogan, PhD1; Tim Holbrook, BSc2; Fritha Hennessy, PhD2; Will Ambler, PhD2; Oliver-Thomas Carter, BSc2; Cindy Garris, MS1
1ViiV Healthcare, Durham, NC, USA; 2Adelphi Real World, Bollington, UK
|
| |
|
|
|
|
|
